Title : Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors.

Pub. Date : 2016 Oct

PMID : 27497712






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Post-marketing safety evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir: A drug-use investigation in patients with high risk factors. peramivir neuraminidase 1 Homo sapiens
2 Peramivir, the only injectable anti-influenza neuraminidase inhibitor medically available in Japan at present, is considered first-line treatment in patients with high risk factors for influenza exacerbation. peramivir neuraminidase 1 Homo sapiens